Topic outline
Methods of utilizing NGS test results (off-label, clinical trial, etc.)
Information on the topics listed on this slide will be presented in the lecture.
- ・Cancer genomic medicine and comprehensive genomic profiling (CGP) test
- ・Treatment based on cancer genomic profiling
0:18:25
Cancer Genome Medicine Delivery System (Status in Europe and the United States)
Information on the topics listed on this slide will be presented in the lecture.
1 Evolution of cancer molecular targets, testing, and related therapeutics
1.1 Whole Genome Transcriptome Sequencing Potential Applications in Breast Cancer
2 Evolution of clinical trials
3 Molecular genomic testing coverage and reimbursement0:36:13
Cancer Genomic Medicine System (Status in Japan)
This content will discuss these three main topics,
1.Cancer Genomic Medicine System
2.Expert Panel
3.Actual Operations0:20:37
Expert Panel System/Molecular Tumor Board in Japan
1. Role of the expert panel
・What is an expert panel?
・Expert panels and the cancer genome-based medicine system in Japan
2. Treatment strategies based on the results of oncogene panel tests
・Selection of treatment
・Role of clinical trials
・Treatment strategies decided by attending physicians0:29:40
About C-CAT
This lecture will introduce the National Platform of Cancer Genomic Medicine in Japan.
- 1. Center for Cancer Genomics and Advanced Therapeutics: C-CAT
- 2. Official scheme of basket-type off-label use
- 3. Medical and research use of C-CAT “real-world” data
0:06:20
Algorithms for C-CAT results
Information on the topics listed on this slide will be presented in the lecture.
1.Significance of mutations, evidence level classification
2.Explanation of C-CAT Findings results
3.Knowledge database and report logic
4.Knowledge database curation
5.Medical search portal0:31:12
Medical Ethics and Personal Information Protection
Information on the topics listed on this slide will be presented in the lecture.
- ・Handling patient information
- ・ELSI in cancer genomic medicine (ELSI: Ethical, Legal, and Social Issues)
0:23:34
- ・Handling patient information
Procedures to conduct multinational clinical trials
Information on the topics listed on this slide will be presented in the lecture.
- ・Regulatory changes and global trends in multi-regional clinical trials
- ・Importance of investigator-initiated registration-directed trials (IIRDTs)
- ・Operational management in MRCTs
0:24:58
- ・Regulatory changes and global trends in multi-regional clinical trials